Michael J. Lenardo

Last updated

Dr. Michael J. Lenardo, is the chief of the Molecular Development and Immune System Section and the founder and co-Director of the Clinical Genomics Program at the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH). [1] Trained as a geneticist, molecular biologist, and immunologist, his research examines how cells of the immune system defend themselves against various pathogens, including viruses and bacteria. [2] His research has investigated genetic abnormalities in the immune system, mechanisms of cell death, genetic diseases of immune homeostasis and autoimmunity, and development of novel diagnostics and therapeutics for diseases of the immune system. [1] [2] [3] Lenardo's contributions to science and medicine have shown the possibilities of genomic research in developing precision medicine diagnoses and treatments for disease in humans. [4] In 2006 he was appointed Officer of the Most Excellent Order of the British Empire (O.B.E.) by Queen Elizabeth II. [1]  In 2019 he was inducted into the National Academies of Sciences and the National Academy of Medicine, considered among the highest honors awarded to a U.S scientist and medical researcher respectively. [1]

Contents

Dr. Michael J. Lenardo, M.D.
Lenardo Portrait.jpg
Personal details
Born (1955-12-01) December 1, 1955 (age 68)
Chicago, Illinois, U.S.
Education Johns Hopkins University (BA)
Washington University School of Medicine (MD)
Awards Irish Society of Immunology Award
American Association of Immunologists Steinman Award for Human Immunology Research
Scientific career
Fields Molecular immunology
Molecular genetics
Institutions

Early life and education

Lenardo was born on December 1, 1955, in Chicago, Illinois, to Elizabeth (nee O'Leary; 1925–2008) and Guido D. Lenardo (1923–2011), a physician. [4] [5] [6] He became interested in genetics while a student at Campion Jesuit High School during a senior project in which he prepared karyotypes of chromosomes for a hospital laboratory investigating birth defects in infants. [2] [7] His research interests branched into molecular genetics while an undergraduate student at Johns Hopkins University in Baltimore, Maryland, where he worked in a laboratory within the Department of Medical Genetics at the medical school. [7] He graduated in 1977 with a Bachelor of Arts (B.A.) in Natural Sciences. [2] [8] He continued his research at Washington University in St. Louis, where he was introduced to molecular biology through virus research. [7] He obtained a Doctor of Medicine (M.D.) in 1981. [8] Upon graduating, Lenardo married Dr. Lesley-Anne Furlong, M.D., a fellow medical school classmate. [7]

Career

Following graduation, Lenardo pursued an internship in internal medicine at the University of Iowa Hospitals and Clinics. [7] Subsequently, he was accepted into a fellowship program for oncology research at the University of Iowa’s Division of Hematology-Oncology. [7] He carried out molecular biology research in the laboratory of Dr. John Donelson, whose postdoctoral work involved contributions to British biochemist and Nobel Laureate Frederick Sanger’s second Nobel Prize for DNA sequencing. [7] [9] In Donelson’s laboratory, Lenardo was introduced to advanced molecular techniques, including DNA manipulation and sequencing, which encouraged him to pursue molecular research rather than clinical work. [7] [9]

After the fellowship, Lenardo began postdoctoral training at the newly opened Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology. [8] He conducted research in molecular biology of mammalian systems and gene regulation under the mentorship of Nobel laureates David Baltimore and Philip Sharp. [8] [10] His post-doctoral training was productive and involved developing the functional assay for the newly described NF-kB binding complex, providing first evidence of the role of NF-kB in innate immunity, and co-discovering the Oct4 nuclear factor with Louis M. Staudt, among other contributions. [11] [12] [13] Following the completion of his postdoctoral fellowship, he became an independent principal investigator at NIAID, National Institutes of Health. [7]

National Institutes of Health

In 1989, Lenardo established an independent research section in the Laboratory of Immunology at NIAID, later becoming a senior investigator and section chief. [4] He was named a NIH Distinguished Investigator in 2019, a title reserved only for the top 2-3% of investigators across all 27 institutes and centers at NIH. [1] [14]

Lenardo has published over 250 scholarly works and holds a number of medical patents. [1] [7] His work investigates human genetic immunodeficiencies through direct clinical research informed by a range of contemporary molecular, biochemical, and immunological approaches. [4] [15] This has resulted in the discovery of fundamental principles of cellular homeostasis involving previously unidentified molecules, including Fas, Caspase 8, Caspase 10, PI-3 kinase p110, CTLA-4 and its regulator LRBA, CD55, and the MagT1 magnesium transporter. [4] As a result of Lenardo’s expansive approach, his laboratory has been able to define the first human genetic disease related to each of these molecules, including Autoimmune Lymphoproliferative Syndrome, Caspase-8 deficiency syndrome, PASLI disease, XMEN disease, and most recently CHAI and LATIAE disease. [4] [8] [16]

Lenardo's work reveals how these molecules control the homeostasis of both immune and non-immune cell types. [4] In so doing, it has illuminated the origins and mechanics of various underlying immunological and genetic disease processes, together with concepts for successful treatments. [4] His lab’s 2017 identification of CD55 deficiency (which they named CHAPLE disease) led to the discovery of a safe and highly effective long-term treatment for a previously incurable, extremely debilitating and progressive disease. [17] [18] His discoveries have been found to be broadly applicable to common diseases such as cancer. [4]

Lenardo has served on editorial boards for the European Journal of Immunology, the Journal of Experimental Medicine, Science Magazine, Magnesium Research, and Biology Direct. [8] He is an Adjunct Professor of Pathology at the University of Pennsylvania School of Medicine, and a Life Visiting Fellow at Clare Hall College Cambridge University. [8] [19] Lenardo has been a strong proponent of mentorship for emerging young scientists at the National Institutes of Health. [2] He has been a member of the Board of Trustees of The Johns Hopkins University (1977–1981), is a member of the American Association for the Advancement of Science, elected AAAS Fellow 2009, the American Association of Immunologists, the American Association of Physicians, Federation of Clinical Immunology Societies, the Clinical Immunology Society, the European Society of Immunodeficiencies, and the American Society of Human Genetics. [20]

He has founded or co-founded several joint research programs including the NIH-Oxford-Cambridge Scholars Program (OxCam), the NIH-University of Pennsylvania Immunology Graduate Partnership Program, the NIH-Marshall Scholars, the NIH-Rhodes Scholars, the National M.D./Ph.D. Partnership Training Program, and the NIH-Institut Pasteur Infectious Disease and Immunology Program. [8] [10] [21]

Music

Lenardo is a member of The Affordable Rock ‘n’ Roll Act, a band composed of NIH physicians, scientists, and researchers, including NIH Director Francis Collins. [22] Lenardo sings and plays guitar. The band has performed at the Library of Congress, National Building Museum, and several NIH events. [22] Of performing with the band, Lenardo has stated, “I find that music—both listening and performing—unleashes creativity and optimism, which helps my scientific work on these devastating diseases.” [22]

Awards and honors

Books

General Interest Articles

See also

Related Research Articles

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services (HHS).

The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

<span class="mw-page-title-main">Wistar Institute</span> American biomedical research institute

The Wistar Institute is an independent, nonprofit research institution in biomedical science with special focuses in oncology, immunology, infectious disease and vaccine research. Located on Spruce Street in Philadelphia’s University City neighborhood, Wistar was founded in 1892 as a nonprofit institution to focus on biomedical research and training.

<span class="mw-page-title-main">Kevin J. Tracey</span>

Kevin J. Tracey, a neurosurgeon and inventor, is the president and CEO of the Feinstein Institute for Medical Research, professor of neurosurgery and molecular medicine at the Zucker School of Medicine, and president of the Elmezzi Graduate School of Molecular Medicine in Manhasset, New York. The Public Library of Science Magazine, PLOS Biology, recognized Tracey in 2019 as one of the most cited researchers in the world.

<span class="mw-page-title-main">Vaccine Research Center</span>

The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.

<span class="mw-page-title-main">John J. O'Shea</span> American physician and immunologist

John J. O'Shea is an American physician and immunologist.

Barton Ford Haynes is an American physician and immunologist internationally recognized for work in T-cell immunology, retrovirology, and HIV vaccine development. Haynes is a Frederic M. Hanes Professor of Medicine and Immunology at Duke University Medical Center. He is the director of the Duke Human Vaccine Institute and the Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID), which was funded by the National Institute of Allergy and Infectious Diseases (NIAID) in 2012. In addition, Haynes directs the B-cell Lineage Envelope Design Study, the Centralized Envelope Phase I Study, and the Role of IgA in HIV-1 Protection Study as part of the Collaboration for AIDS Vaccine Discovery (CAVD), which was funded by the Bill and Melinda Gates Foundation in 2006.

C. Garrison Fathman is a Professor of Medicine and Division Chief of Immunology and Rheumatology at Stanford University School of Medicine. He is also the Associate Director of the Institute for Immunity, Transplantation and Infection and Director of the Center for Clinical Immunology at Stanford University. He was Founder and first-President of the Federation of Clinical Immunology Societies. As Director of the CCIS, Dr. Fathman initiated a multidisciplinary approach to study and treat autoimmune diseases, including rheumatoid arthritis, multiple sclerosis, and insulin-dependent diabetes mellitus, and initiated several new approaches to education and community outreach.

<span class="mw-page-title-main">XMEN disease</span> Medical condition

XMEN disease is a rare genetic disorder of the immune system that illustrates the role of glycosylation in the function of the immune system. XMEN stands for “X-linked MAGT1 deficiency with increased susceptibility to Epstein–Barr virus (EBV) infection and N-linked glycosylation defect.” The disease is characterized by CD4 lymphopenia, severe chronic viral infections, and defective T-lymphocyte activation. Investigators in the laboratory of Dr. Michael Lenardo, National Institute of Allergy and Infectious Diseases at the National Institutes of Health first described this condition in 2011.

<span class="mw-page-title-main">Caspase-8 deficiency</span> Medical condition

Caspase-8 deficiency (CEDS) is a very rare genetic disorder of the immune system. It is caused by mutations in the CASP8 gene that encodes the protein caspase-8. The disorder is characterized by splenomegaly and lymphadenopathy, in addition to recurrent sinopulmonary infections, recurrent mucocutaneous herpesvirus or other viral infections, and hypogammaglobulinemia. Investigators in the laboratory of Dr. Michael Lenardo at the National Institutes of Health described this condition in two siblings from a consanguineous family in 2002, and several more affected family members have since been identified.

Bernard Moss is a virologist at the National Institute of Allergy and Infectious Diseases, part of the United States National Institutes of Health. He is the Chief of the NIAID Laboratory of Viral Diseases and of the NIAID Genetic Engineering Section. He is known for his work on poxviruses.

<span class="mw-page-title-main">Lauren V. Wood</span> American allergist, immunologist

Lauren V. Wood is an American allergist, immunologist, and staff physician at the National Cancer Institute (NCI) at the National Institutes of Health (NIH) in Bethesda, Maryland, where she has served as a principal investigator. She is known for conducting studies of vaccines for cancer, Human papillomavirus (HPV), Hepatitis C, and HIV especially for use with children, teens and young adults. She holds the rank of captain in the U.S. Public Health Service (PHS).

<span class="mw-page-title-main">Julie Ledgerwood</span> American allergist and immunologist

Julie E. Ledgerwood is an American allergist and immunologist, who is the chief medical officer and serves as chief of the Clinical Trials Program at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health in Bethesda, Maryland. She is a Doctor of Osteopathic Medicine.

<span class="mw-page-title-main">Stephen Straus</span> American virologist and science administrator

Stephen E. Straus was an American physician, immunologist, virologist and science administrator. He is particularly known for his research into human herpesviruses and chronic fatigue syndrome, and for his discovery of the autoimmune lymphoproliferative syndrome genetic disorder. He headed the Laboratory of Clinical Investigation of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), and served as the founding director of the NIH's National Center for Complementary and Alternative Medicine.

<span class="mw-page-title-main">John I. Gallin</span> American medical researcher

John I. Gallin is an American medical researcher who has contributed to the understanding of innate immunity but especially chronic granulomatous disease, a phagocyte disorder. Gallin was appointed director of the NIH Clinical Center on May 1, 1994, and served until January 8, 2017. He serves as the chief scientific officer for the Clinical Center and associate director for clinical research at the National Institutes of Health.

<span class="mw-page-title-main">Emily Erbelding</span> American physician and scientist

Emily J. Erbelding is an American physician-scientist. She is the director of the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID). Erbelding was previously deputy director of the Division of AIDS at NIAID. She was a faculty member at Johns Hopkins School of Medicine and served as director of clinical services for the Baltimore City Health Department STD/HIV program.

<span class="mw-page-title-main">Irini Sereti</span> Greek scientist and physician

Irini Sereti is a Greek scientist and physician. She is chief of the HIV pathogenesis section at the National Institute of Allergy and Infectious Diseases. Sereti researches immune reconstitution inflammatory syndrome, idiopathic CD4 lymphocytopenia, and immune-based therapeutic strategies of HIV investigation.

<span class="mw-page-title-main">Niki Moutsopoulos</span> Greek periodontist and immunologist

Niki M. Moutsopoulos is a Greek periodontist and immunologist. She is a senior investigator in the oral immunity and infection section at the National Institute of Dental and Craniofacial Research. Moutsopoulos specializes in oral immunology and periodontitis. Her research program focuses on host-microbial interactions that can drive chronic inflammatory responses and tissue destruction in the oral cavity.

<span class="mw-page-title-main">Weatherall Institute of Molecular Medicine</span>

The MRC Weatherall Institute of Molecular Medicine at the University of Oxford is a research institute located at the John Radcliffe Hospital in Oxford. Founded in 1989 by Sir David Weatherall, the institute focuses on furthering our understanding of clinical medicine at a molecular level. It was one of the first institutes of its kind in the world to be dedicated to research in this area.

<span class="mw-page-title-main">John R. Mascola</span> American Physician-Scientist

John R. Mascola is an American physician-scientist, immunologist and infectious disease specialist. He was the director of the Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). He also served as a principal advisor to Anthony Fauci, director of NIAID, on vaccines and biomedical research affairs. Mascola is the current Chief Scientific Officer for ModeX Therapeutics.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 "Michael Lenardo, M.D. | NIH: National Institute of Allergy and Infectious Diseases". www.niaid.nih.gov. Retrieved 2020-12-14.
  2. 1 2 3 4 5 6 Worthing, Brooke (2020-02-28). "IRP's Michael Lenardo Elected to National Academy of Sciences". NIH Intramural Research Program. Retrieved 2020-12-14.
  3. ↑ "Principal Investigators". NIH Intramural Research Program. Retrieved 2020-12-14.
  4. 1 2 3 4 5 6 7 8 9 "Michael Lenardo". www.nasonline.org. Retrieved 2020-12-14.
  5. ↑ "Obituary for Guido D. Lenardo, M.D. at Nelson Funeral Home". www.nelsonfunerals.com. Retrieved 2021-12-29.
  6. ↑ "Elizabeth M. "Betty" O'Leary Lenardo..." www.findagrave.com. Retrieved 2021-12-29.
  7. 1 2 3 4 5 6 7 8 9 10 Patterson, Maureen (2019). "Former Iowa Fellow Follows the Genes to a Rewarding Career" (PDF).
  8. 1 2 3 4 5 6 7 8 "Biohealth Innovation - Michael Lenardo, M.D., Chief, Molecular Development of the Immune System Section NIAID/DIR, guests on BioTalk". www.biohealthinnovation.org. Retrieved 2020-12-14.
  9. 1 2 "John Donelson, PhD to be recognized as Distinguished Mentor | Carver College of Medicine". medicine.uiowa.edu. Retrieved 2020-12-14.
  10. 1 2 Bendis, BioTalk with Rich. "BioTalk with Rich Bendis - Michael Lenardo, M.D., National Institutes of Health (NIH) NIAID/DIR (EP.45)". Google Podcasts. Retrieved 2020-12-14.
  11. ↑ Wan, Fengyi; Lenardo, Michael J. (2009-10-01). "Specification of DNA Binding Activity of NF-κB Proteins". Cold Spring Harbor Perspectives in Biology. 1 (4): a000067. doi:10.1101/cshperspect.a000067. ISSN   1943-0264. PMC   2773628 . PMID   20066093.
  12. ↑ Lenardo, Michael J.; Fan, Chen-Ming; Maniatis, Tom; Baltimore, David (April 1989). "The involvement of NF-κB in β-interferon gene regulation reveals its role as widely inducible mediator of signal transduction". Cell. 57 (2): 287–294. doi:10.1016/0092-8674(89)90966-5. PMID   2495183. S2CID   54275135.
  13. ↑ Lenardo, M.; Staudt, L; Robbins, P; Kuang, A; Mulligan, R.; Baltimore, D (1989-01-27). "Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor". Science. 243 (4890): 544–546. Bibcode:1989Sci...243..544L. doi:10.1126/science.2536195. ISSN   0036-8075. PMID   2536195.
  14. ↑ "Trevor Archer named NIH Distinguished Investigator (Environmental Factor, December 2019)". National Institute of Environmental Health Sciences. Retrieved 2020-12-14.
  15. ↑ "Michael J. Lenardo". American Academy of Arts & Sciences. Retrieved 2020-12-14.
  16. ↑ Lo, Bernice; Fritz, Jill M.; Su, Helen C.; Uzel, Gulbu; Jordan, Michael B.; Lenardo, Michael J. (2016-08-25). "CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency". Blood. 128 (8): 1037–1042. doi:10.1182/blood-2016-04-712612. ISSN   0006-4971. PMC   5000841 . PMID   27418640.
  17. ↑ Ozen, Ahmet; Comrie, William A.; Ardy, Rico C.; Domínguez Conde, Cecilia; Dalgic, Buket; Beser, Ömer F.; Morawski, Aaron R.; Karakoc-Aydiner, Elif; Tutar, Engin; Baris, Safa; Ozcay, Figen (2017-07-06). "CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis". New England Journal of Medicine. 377 (1): 52–61. doi:10.1056/NEJMoa1615887. ISSN   0028-4793. PMC   6690356 . PMID   28657829.
  18. ↑ Kurolap, Alina; Eshach Adiv, Orly; Hershkovitz, Tova; Tabib, Adi; Karbian, Netanel; Paperna, Tamar; Mory, Adi; Vachyan, Arcadi; Slijper, Nadav; Steinberg, Ran; Zohar, Yaniv (March 2019). "Eculizumab Is Safe and Effective as a Long-term Treatment for Protein-losing Enteropathy Due to CD55 Deficiency". Journal of Pediatric Gastroenterology and Nutrition. 68 (3): 325–333. doi:10.1097/MPG.0000000000002198. ISSN   0277-2116. PMID   30418410. S2CID   53281594.
  19. ↑ Michael J. Lenardo. "Biographical Sketch" (PDF) (selected CV). National Institutes of Health. Archived from the original (PDF) on 2017-04-28. Retrieved 2020-12-14.
  20. ↑ "Michael Lenardo, M.D. | NIH: National Institute of Allergy and Infectious Diseases". www.niaid.nih.gov. Retrieved 2021-12-29.
  21. ↑ "Meet the Directors | NIH MD/PHD Partnership Training Program". mdphd.gpp.nih.gov. Retrieved 2020-12-14.
  22. 1 2 3 "Doc Rock | Page 4 of 4". Bethesda Magazine. 2019-11-04. Retrieved 2020-12-14.
  23. ↑ "Dr Michael Lenardo | The Academy of Medical Sciences". acmedsci.ac.uk. Retrieved 2020-12-14.
  24. ↑ National Association of Fellowships Advisors. Biennial Conference (2009). Leading the way : student engagement and nationally competitive awards. Suzanne McCray, National Association of Fellowships Advisors. Fayetteville: University of Arkansas Press. ISBN   978-1-61075-231-2. OCLC   787842896.
  25. ↑ Courtland, Rachel (April 2010). "How supermassive black holes become cosmic gluttons". New Scientist. 206 (2757): 13. doi:10.1016/s0262-4079(10)60983-9. ISSN   0262-4079.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.